Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Mar 2017 – 20 Aug 2026, limited by Groww Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Groww Value Fund | Nifty 500 |
|---|---|---|
| 09 Mar 2017 | ₹100.00 | ₹100.00 |
| 22 Dec 2017 | ₹115.67 | ₹122.33 |
| 05 Oct 2018 | ₹93.89 | ₹111.87 |
| 20 Jul 2019 | ₹91.02 | ₹120.68 |
| 02 May 2020 | ₹80.66 | ₹103.93 |
| 14 Feb 2021 | ₹118.48 | ₹162.24 |
| 29 Nov 2021 | ₹137.58 | ₹190.10 |
| 12 Sep 2022 | ₹142.29 | ₹202.04 |
| 27 Jun 2023 | ₹146.44 | ₹209.64 |
| 09 Apr 2024 | ₹198.77 | ₹269.66 |
| 22 Jan 2025 | ₹198.78 | ₹277.52 |
| 05 Nov 2025 | ₹227.28 | ₹307.07 |
| 20 Aug 2026 | ₹226.19 | ₹304.97 |
| Metric | Groww · Regular · IDCW NAV ₹22.65 Very High risk ★★★★☆ | Category median Value Fund · 27 funds |
|---|---|---|
| +1.88% | +1.55% | |
| +13.91% | +10.75% | |
| +11.55% | +10.54% | |
| — | +7.06% | |
| +9.02% | +8.32% | |
| +11.05% | — | |
| +11.89% | +10.45% | |
| +12.46% | +8.52% | |
| — | +6.67% | |
| Risk | ||
| 13.63% | 15.42% | |
| 0.54 | 0.30 | |
| 0.75 | 0.39 | |
| -48.21% | -47.99% | |
| Nifty 500 | — | |
| +1.91% | -0.99% | |
| 0.95 | 0.95 | |
| 99.4% | 99.4% | |
| 87.9% | 105.5% | |
| 2.87% | 2.35% | |
| ₹66.81Cr | ₹1,405Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| 40% | 40% | |
| Nikhil Satam | — | |
| 09 Mar 2017 | — | |
| 67 | — | |
| 36.0% | — | |
| 8.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.